bf/NYSE:CLB_icon.jpeg

NYSE:CLB

Core Laboratories N.V.

  • Stock

USD

Last Close

24.35

26/07 20:00

Market Cap

979.74M

Beta: 2.67

Volume Today

519.84K

Avg: 365.41K

PE Ratio

41.91

PFCF: 78.00

Dividend Yield

0.27%

Payout:8.37%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
48.04M
-
45.10M
6.13%
42.14M
6.56%
37.31M
11.45%
33.52M
10.17%
39.49M
17.82%
47.91M
21.33%
44.16M
7.84%
41.80M
5.34%
52.94M
26.67%
66.07M
24.80%
average payables
52.99M
-
48.95M
7.63%
40.28M
17.72%
33.60M
16.59%
37.71M
12.24%
41.43M
9.86%
38.38M
7.35%
29.32M
23.61%
26.38M
10.04%
37.79M
43.26%
39.68M
5.00%
average receivables
193.05M
-
199.24M
3.21%
171.43M
13.96%
130.01M
24.16%
123.71M
4.84%
131.13M
5.99%
130.37M
0.58%
107.39M
17.63%
90.01M
16.18%
101.87M
13.18%
108.13M
6.15%
book value per share
3.76
-
2.15
42.65%
-0.56
125.96%
3.52
728.94%
3.37
4.23%
3.64
8.05%
4.11
12.82%
1.70
58.62%
3.50
105.95%
4.08
16.54%
4.93
20.78%
capex per share
-0.86
-
-0.86
0.64%
-0.57
33.28%
-0.27
53.69%
-0.43
60.41%
-0.49
15.66%
-0.50
2.08%
-0.27
46.80%
-0.29
10.17%
-0.22
25.07%
-0.22
0.96%
capex to depreciation
-1.53
-
-1.40
8.28%
-0.88
37.01%
-0.44
50.70%
-0.75
72.84%
-0.94
25.09%
-0.99
4.61%
-0.57
42.21%
-0.73
28.43%
-0.60
18.59%
-0.67
12.59%
capex to operating cash flow
-0.13
-
-0.12
5.55%
-0.11
10.27%
-0.09
19.84%
-0.15
70.25%
-0.19
28.68%
-0.25
27.94%
-0.21
17.47%
-0.37
80.29%
-0.41
10.60%
-0.43
4.25%
capex to revenue
-0.04
-
-0.03
4.90%
-0.03
11.84%
-0.02
35.30%
-0.03
44.60%
-0.03
9.02%
-0.03
7.43%
-0.02
26.84%
-0.03
18.09%
-0.02
27.55%
-0.02
0.52%
cash per share
0.56
-
0.54
3.80%
0.53
0.80%
0.33
37.00%
0.33
2.47%
0.30
9.03%
0.25
15.72%
0.31
24.13%
0.38
23.96%
0.33
13.46%
0.32
4.45%
days of inventory on hand
24.82
-
22.88
7.84%
26.66
16.52%
26.21
1.66%
24.36
7.07%
32.05
31.56%
35.33
10.25%
35.20
0.39%
42.92
21.96%
53.70
25.11%
62.95
17.22%
days payables outstanding
26.94
-
24.84
7.83%
21.81
12.17%
26.21
20.17%
30.49
16.31%
28.88
5.26%
25.08
13.16%
21.24
15.30%
28.08
32.17%
40.73
45.07%
29.42
27.78%
days sales outstanding
68.45
-
66.31
3.12%
66.68
0.55%
70.17
5.23%
73.63
4.94%
67.26
8.64%
71.87
6.85%
62.32
13.30%
75.16
20.60%
79.68
6.02%
78.29
1.74%
debt to assets
0.39
-
0.51
31.78%
0.67
30.58%
0.35
47.45%
0.36
2.44%
0.46
28.89%
0.49
6.53%
0.58
16.69%
0.43
25.08%
0.38
10.75%
0.29
23.94%
debt to equity
1.51
-
3.67
142.75%
-17.59
579.26%
1.29
107.35%
1.41
9.16%
1.87
32.18%
2.10
12.36%
4.33
106.41%
1.55
64.07%
1.18
24.28%
0.74
37.09%
dividend yield
0.01
-
0.02
149.15%
0.02
20.54%
0.02
12.22%
0.02
11.87%
0.04
83.61%
0.06
58.36%
0.01
81.92%
0.00
83.07%
0.00
10.42%
0.00
12.81%
earnings yield
0.03
-
0.05
73.91%
0.02
49.17%
0.01
51.63%
0.02
42.55%
0.03
75.46%
0.06
102.41%
-0.08
234.89%
0.02
123.34%
0.02
7.77%
0.05
135.51%
enterprise value
8.85B
-
5.58B
36.93%
5.02B
10.16%
5.50B
9.67%
5.05B
8.22%
2.91B
42.29%
2.04B
29.94%
1.49B
26.91%
1.26B
15.63%
1.15B
8.96%
1.04B
9.30%
enterprise value over ebitda
26.56
-
16.11
39.32%
27.26
69.18%
63.84
134.18%
36.76
42.42%
20.56
44.06%
17.11
16.77%
19.47
13.76%
19.74
1.39%
19.53
1.06%
14.94
23.50%
ev to operating cash flow
29.70
-
18.40
38.04%
22.90
24.42%
41.71
82.19%
40.63
2.59%
26.06
35.87%
22.80
12.49%
25.79
13.08%
34.42
33.47%
45.93
33.43%
41.93
8.69%
ev to sales
8.25
-
5.15
37.61%
6.29
22.25%
9.25
47.07%
7.65
17.27%
4.16
45.67%
3.06
26.52%
3.06
0.23%
2.68
12.58%
2.34
12.59%
2.04
12.87%
free cash flow per share
5.75
-
6.10
6.07%
4.60
24.57%
2.72
40.80%
2.39
12.22%
2.04
14.71%
1.52
25.59%
1.03
31.81%
0.50
51.57%
0.32
36.47%
0.30
6.01%
free cash flow yield
0.03
-
0.05
68.31%
0.04
16.53%
0.02
46.37%
0.02
3.82%
0.03
56.61%
0.04
17.84%
0.04
3.10%
0.02
42.45%
0.02
30.08%
0.02
7.88%
graham net net
-6.48
-
-8.91
37.54%
-11.72
31.58%
-6.80
41.96%
-6.91
1.60%
-8.03
16.21%
-10.32
28.44%
-8.94
13.33%
-6.67
25.43%
-5.69
14.70%
-4.75
16.57%
graham number
21.33
-
16.91
20.72%
5.84
65.47%
10.70
83.26%
11.95
11.62%
12.14
1.61%
14.57
20.08%
9.13
37.33%
5.81
36.39%
6.21
6.82%
9.77
57.42%
income quality
1.23
-
1.17
4.29%
1.91
62.48%
2.07
8.34%
1.50
27.59%
1.40
6.28%
0.96
31.83%
-0.60
162.49%
1.81
403.02%
1.27
29.83%
0.61
52.30%
intangibles to total assets
0.33
-
0.33
0.75%
0.39
17.04%
0.45
15.03%
0.43
2.94%
0.45
4.54%
0.46
0.59%
0.39
14.98%
0.38
2.82%
0.36
4.24%
0
100%
interest coverage
35.79
-
32.69
8.65%
13.01
60.20%
7.45
42.76%
10.48
40.66%
8.90
15.03%
6.58
26.05%
3.88
41.04%
4.95
27.44%
3.59
27.43%
4.01
11.60%
interest debt per share
5.89
-
8.15
38.46%
10.13
24.31%
4.81
52.52%
5.00
3.90%
7.09
41.91%
8.94
26.04%
7.67
14.14%
5.64
26.53%
5.05
10.45%
3.93
22.18%
inventory turnover
14.70
-
15.95
8.51%
13.69
14.18%
13.92
1.69%
14.98
7.60%
11.39
23.99%
10.33
9.30%
10.37
0.39%
8.50
18.00%
6.80
20.07%
5.80
14.69%
invested capital
1.51
-
3.67
142.75%
-17.59
579.26%
1.29
107.35%
1.41
9.16%
1.87
32.18%
2.10
12.36%
4.33
106.41%
1.55
64.07%
1.18
24.28%
0.74
37.09%
market cap
8.61B
-
5.25B
39.02%
4.61B
12.25%
5.30B
15.02%
4.84B
8.74%
2.64B
45.48%
1.67B
36.64%
1.18B
29.44%
1.03B
12.94%
939.19M
8.50%
839.26M
10.64%
net current asset value
-187.75M
-
-279.84M
49.05%
-410.41M
46.66%
-231.29M
43.64%
-228.65M
1.14%
-256.95M
12.38%
-371.30M
44.50%
-327.16M
11.89%
-230.80M
29.45%
-177.70M
23.01%
-135.56M
23.71%
net debt to ebitda
0.73
-
0.96
32.30%
2.22
131.25%
2.34
5.44%
1.55
33.89%
1.95
26.16%
3.11
59.17%
4.09
31.49%
3.65
10.76%
3.53
3.28%
2.88
18.38%
net income per share
5.38
-
5.90
9.60%
2.71
54.07%
1.45
46.60%
1.88
30.09%
1.80
4.44%
2.30
27.80%
-2.18
194.93%
0.43
119.65%
0.42
2.08%
0.86
105.19%
operating cash flow per share
6.61
-
6.95
5.20%
5.17
25.65%
2.99
42.23%
2.81
5.78%
2.53
10.12%
2.02
20.21%
1.30
35.54%
0.80
38.89%
0.54
32.25%
0.52
3.15%
payables turnover
13.55
-
14.70
8.49%
16.73
13.86%
13.92
16.79%
11.97
14.02%
12.64
5.55%
14.55
15.15%
17.18
18.07%
13.00
24.34%
8.96
31.07%
12.41
38.47%
receivables turnover
5.33
-
5.50
3.22%
5.47
0.55%
5.20
4.97%
4.96
4.70%
5.43
9.46%
5.08
6.41%
5.86
15.33%
4.86
17.08%
4.58
5.68%
4.66
1.77%
research and ddevelopement to revenue
return on tangible assets
0.55
-
0.57
4.13%
0.30
47.33%
0.20
32.86%
0.25
24.51%
0.22
10.65%
0.24
7.94%
-0.28
215.16%
0.05
119.54%
0.05
3.45%
0.07
31.08%
revenue per share
23.80
-
24.87
4.48%
18.82
24.32%
13.47
28.42%
14.94
10.94%
15.85
6.09%
15.06
4.98%
10.96
27.28%
10.22
6.71%
10.57
3.41%
10.73
1.49%
roe
1.43
-
2.74
91.11%
-4.85
276.90%
0.41
108.49%
0.56
35.84%
0.49
11.56%
0.56
13.28%
-1.28
329.41%
0.12
109.54%
0.10
15.98%
0.17
69.89%
roic
0.59
-
0.61
3.36%
0.32
47.90%
0.21
34.58%
0.26
23.65%
0.20
23.83%
0.17
11.02%
0.13
27.24%
0.05
57.57%
0.06
10.22%
0.12
102.22%
sales general and administrative to revenue
0.05
-
0.04
13.13%
0.06
48.22%
0.07
6.22%
0.07
9.24%
0.09
24.07%
0.07
19.94%
0.07
2.82%
0.09
34.49%
0.08
17.14%
shareholders equity per share
3.76
-
2.15
42.65%
-0.56
125.96%
3.52
728.94%
3.37
4.23%
3.64
8.05%
4.11
12.82%
1.70
58.62%
3.50
105.95%
4.08
16.54%
4.93
20.78%
stock based compensation to revenue
0.02
-
0.02
1.35%
0.03
41.45%
0.04
39.14%
0.03
6.34%
0.05
40.32%
0.03
35.96%
0.02
51.44%
0.04
167.57%
0.02
60.99%
-0.12
843.66%
tangible asset value
-48.93M
-
-130.83M
167.38%
-267.20M
104.24%
-101.41M
62.05%
-105.56M
4.09%
-134.03M
26.98%
-172.09M
28.40%
-145.48M
15.46%
-58.46M
59.82%
-20.29M
65.29%
234.07M
1,253.57%
tangible book value per share
-0.11
-
-1.86
1,611.97%
-5.00
169.01%
-0.76
84.74%
-0.90
17.88%
-1.62
80.01%
-1.10
32.13%
-0.73
33.58%
1.16
259.11%
1.77
52.48%
4.93
178.22%
working capital
168.09M
-
169.95M
1.11%
117.79M
30.69%
82.44M
30.01%
102.41M
24.23%
128.43M
25.41%
109.64M
14.63%
76.10M
30.59%
98.27M
29.14%
108.57M
10.47%
135.49M
24.80%

All numbers in USD (except ratios and percentages)